Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Non-Hodgkin Lymphomas (NHL)-a Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Nilanjan Ghosh, MD PhD, Sairah Ahmed, MD, Carlos Litovich, MPH, Kwang Woo Ahn, PhD, Manoj Khanal, Mohamed A Kharfan-Dabaja, MDMBA, Anna Sureda, MD PhD, Timothy S. Fenske, MD, Mehdi Hamadani, MD

Blood (2019) 134 (Supplement_1): 319.

https://doi.org/10.1182/blood-2019-121849

Published: 2019

Journal Articles

Outcomes of Patients with Chronic Lymphocytic Leukemia Admitted with Sepsis: An Analysis of National Inpatient Sample Database

Prasanth Lingamaneni, Muhammad Zain Farooq, MD MBBS, Ishaan Vohra, MD, Shristi Upadhyay, MD, Sindhu Malapati, MD, Sunny R K Singh, MD

Blood (2019) 134 (Supplement_1): 5460.

https://doi.org/10.1182/blood-2019-131646

Published: 2019

Journal Articles

Allo-Immunisation in Sickle Cell Patients in a Large British Specialist Haemoglobinopathy Centre

Sarrah Tayabali, MBBS, BSc, DipRCPath, Karen Madgwick, FIBMS, CSci, DMLM, PgDip, Arne de Kreuk, MD PhD

Blood (2019) 134 (Supplement_1): 2451.

https://doi.org/10.1182/blood-2019-130492

Published: 2019

Journal Articles

Alpha Globin Gene Copy Number Is Associated with Kidney Disease Among Black Individuals

Amy Parker Ruhl, MD MPH, Neal Jeffries, PhD, Yu Yang, MD, Rakhi P. Naik, MD, Lydia H. Pecker, MD, Bryan T. Mott, PhD, Neil A. Zakai, MDMSc, Cheryl A. Winkler, PhD, Jeffrey B. Kopp, MD, Leslie A. Lange, PhD, Marguerite R. Irvin, PhD, Orlando M. Gutierrez, MD, Mary Cushman, MD, Hans C. Ackerman, MD DPhil, MSc

Blood (2019) 134 (Supplement_1): 2248.

https://doi.org/10.1182/blood-2019-121493

Published: 2019

Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD

Blood (2019) 134 (Supplement_1): 13.

https://doi.org/10.1182/blood-2019-123717

Published: 2019

Journal Articles

Fragmentation of Care for Young Adults with Sickle Cell Disease in California

Ashley Shatola, Ann M Brunson, MS, Theresa H.M. Keegan, PhD MS, Ted Wun, MD, Anjlee Mahajan, MD

Blood (2019) 134 (Supplement_1): 4667.

https://doi.org/10.1182/blood-2019-121901

Published: 2019

Journal Articles

Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Sairah Ahmed, MD, Nilanjan Ghosh, MD PhD, Manoj Khanal, Kwang Woo Ahn, PhD, Carlos Litovich, MPH, Timothy S. Fenske, MD, Mohamed A Kharfan-Dabaja, MDMBA, Anna Sureda, MD PhD, Mehdi Hamadani, MD

Blood (2019) 134 (Supplement_1): 3318.

https://doi.org/10.1182/blood-2019-121848

Published: 2019

Journal Articles

Factors Predicting Early Mortality in Newly Diagnosed Myelodysplastic Syndrome (MDS): A Population Based Study

Annie M. Jacobsen, MD, Jenny Poynter, PhD, Michaela Richardson, MPH, Phuong L. Nguyen, MD, Betsy A Hirsch, PhD, Adina Cioc, MD, Michelle A. Roesler, BS, Erica D. Warlick, MD

Blood (2018) 132 (Supplement 1): 4369.

https://doi.org/10.1182/blood-2018-99-112319

Published: 2018

Journal Articles

Telomere Length and Telomerase Complex Mutations Predict Fatal Treatment Toxicity after Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

Mikko Myllymaki, MD PhD, Robert A. Redd, MS, Corey S. Cutler, MD MPH, Wael Saber, MD MS, Zhen-Huan Hu, MPH, Tao Wang, PhD, Stephen R. Spellman, Christopher J. Gibson, MD, Maxine M Chen, Esther Orr, David P. Steensma, MD, Joseph H. Antin, MD, Immaculata De Vivo, Donna S Neuberg, ScD, Suneet Agarwal, MDPhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 796.

https://doi.org/10.1182/blood-2018-99-117031

Published: 2018

Journal Articles

Evidence for Role of Enzymatic Operations in Shared T-Cell Receptors

Mark Woodcock, MD, Adam Buntzman, PhD, Benjamin G. Vincent, MD

Blood (2018) 132 (Supplement 1): 3703.

https://doi.org/10.1182/blood-2018-99-118884

Published: 2018

Journal Articles

Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR

Rajneesh Nath, MD, Zheng Zhou, MD PhD, Jan Cerny, MD PhD, Hai-Lin Wang, MPH, Khalid Bo-Subait, Zartash Guth, Gulrayz Ahmed, Muhammad Wagas Khan, Gerhard Carl Hildebrandt, MD, Hassan B. Alkhateeb, MD, Moussab Damlaj, MD, Mrinal M. Patnaik, MD MBBS, Brenda M. Sandmaier, MD, Daniel J. Weisdorf, MD, Marcos de Lima, MD, Mark R. Litzow, MD, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 3456.

https://doi.org/10.1182/blood-2018-99-116795

Published: 2018

Journal Articles

The Healthcare Burden of Emergency Department Utilization for Multiple Myeloma: A Five Years U.S. Nationwide Study

Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Pavan Tenneti, MD, Rehan Farooqi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3562.

https://doi.org/10.1182/blood-2018-99-119932

Published: 2018

Journal Articles

Economic Benefit of Early Inhospital Diagnosis and Treatment Initiation of Eculizumab in aHUS

Bonnie M.K. Donato, PhD, Michael Ryan, MS, William Irish, PhD, Christoph Gasteyger, MD, Gilbert L'Italien, PhD, Jeffrey Laurence, MD

Blood (2018) 132 (Supplement 1): 3565.

https://doi.org/10.1182/blood-2018-99-112893

Published: 2018

Journal Articles

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Neil A Zakai, MD MSc, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 144.

https://doi.org/10.1182/blood-2018-99-110567

Published: 2018

Journal Articles

Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample

Pauline van Paridon, BSc, Marina Panova-Noeva, Rene van Oerle, Andreas Schulz, Jürgen Prochaska, Natalie Arnold, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Karl J. Lackner, Tilman M. Hackeng, PhD, Hugo ten Cate, MD PhD, Philipp Wild, Henri M.H. Spronk, PhD

Blood (2018) 132 (Supplement 1): 1169.

https://doi.org/10.1182/blood-2018-99-116932

Published: 2018

Journal Articles

Trends of Palliative Care Utilization in Acute Myeloid Leukemia in the United States

Sri Harsha Tella, MD, Anuhya Kommalapati, MD, Charles L. Bennett, MD PhD, Gaurav Goyal, MBBS

Blood (2018) 132 (Supplement 1): 4767.

https://doi.org/10.1182/blood-2018-99-110681

Published: 2018

Journal Articles

Clinical-Pathological Features of Non-Transfusion Dependent Thalassemia in Adults — a Single Center Study in Hong Kong

Ka Lok Luke Chan, MBBS, MPH, MRCP, Vivien W M Mak, Kate F S Leung, Joyce H Y Kwong, Nelson C N Chan, Kelvin C K Cheng, Natalie P H Chan, Daniel H F Fong, Stephen C C Choy, Carmen K M Ng, Johnny K F Ma, Michael L G Wong, Margaret Ng, Harold K K Lee

Blood (2018) 132 (Supplement 1): 4900.

https://doi.org/10.1182/blood-2018-99-113487

Published: 2018

Journal Articles

Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia Patients

Neeraj Y Saini, MD, Jan Cerny, MD PhD, Vanessa Furtado, MD, Imran Puthawala, Angela Desmond, Muthalagu Ramanathan, MD, Rajneesh Nath, MD

Blood (2018) 132 (Supplement 1): 1396.

https://doi.org/10.1182/blood-2018-99-112639

Published: 2018

Journal Articles

The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera

Nikolai A. Podoltsev, MD PhD, Mengxin Zhu, MPH, Amer M. Zeidan, MD, Rong Wang, PhD, Amy J. Davidoff, PhD MS, Scott Huntington, MDMPH, Smith Giri, MBBS, Steven D. Gore, MD, Xiaomei Ma, MD PhD

Blood (2017) 130 (Supplement 1): 354.

https://doi.org/10.1182/blood.V130.Suppl_1.354.354

Published: 2017

Journal Articles

Are Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL) Receiving Pediatric or Adult ALL Regimens: A Population-Based Statewide Evaluation of the Approach to AYA ALL across Pediatric and Adult Cancer Centers

Lori S. Muffly, MD MS, Elysia Alvarez, MD MPH, Daphne Lichtensztajn, MDMPH, Renata Abrahao, MD MSc, Theresa H.M. Keegan, PhD MS, Scarlett Gomez, PhD

Blood (2017) 130 (Supplement 1): 611.

https://doi.org/10.1182/blood.V130.Suppl_1.611.611

Published: 2017

NARROW

Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Non-Hodgkin Lymphomas (NHL)-a Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Outcomes of Patients with Chronic Lymphocytic Leukemia Admitted with Sepsis: An Analysis of National Inpatient Sample Database

Allo-Immunisation in Sickle Cell Patients in a Large British Specialist Haemoglobinopathy Centre

Alpha Globin Gene Copy Number Is Associated with Kidney Disease Among Black Individuals

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Fragmentation of Care for Young Adults with Sickle Cell Disease in California

Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Factors Predicting Early Mortality in Newly Diagnosed Myelodysplastic Syndrome (MDS): A Population Based Study

Telomere Length and Telomerase Complex Mutations Predict Fatal Treatment Toxicity after Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

Evidence for Role of Enzymatic Operations in Shared T-Cell Receptors

Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR

The Healthcare Burden of Emergency Department Utilization for Multiple Myeloma: A Five Years U.S. Nationwide Study

Economic Benefit of Early Inhospital Diagnosis and Treatment Initiation of Eculizumab in aHUS

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample

Trends of Palliative Care Utilization in Acute Myeloid Leukemia in the United States

Clinical-Pathological Features of Non-Transfusion Dependent Thalassemia in Adults — a Single Center Study in Hong Kong

Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia Patients

The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera

Are Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL) Receiving Pediatric or Adult ALL Regimens: A Population-Based Statewide Evaluation of the Approach to AYA ALL across Pediatric and Adult Cancer Centers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only